Orchestra BioMed (OBIO) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free OBIO Stock Alerts $4.39 -0.05 (-1.13%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineContrasting Orchestra BioMed (OBIO) & Its Rivalsamericanbankingnews.com - April 27 at 1:16 AMReviewing Orchestra BioMed (OBIO) & The Competitionamericanbankingnews.com - April 24 at 1:16 AMCritical Review: Orchestra BioMed (OBIO) & Its Peersamericanbankingnews.com - April 20 at 1:40 AMOrchestra BioMed: Continuing the Momentum into a Promising Futuremsn.com - March 31 at 11:03 PMOrchestra BioMed Bolsters Board with Healthcare Industry Veteran David Pacittimsn.com - March 31 at 12:42 PMOrchestra BioMed Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lagfinance.yahoo.com - March 29 at 8:20 AMOrchestra BioMed's (OBIO) Buy Rating Reaffirmed at Chardan Capitalmarketbeat.com - March 28 at 9:24 AMBuy Rating Affirmed for Orchestra BioMed on Strong Financials and Promising BackBeat CNT Clinical Datamarkets.businessinsider.com - March 28 at 2:13 AMOBIO Stock Earnings: Orchestra BioMed Hldgs Beats EPS, Misses Revenue for Q4 2023investorplace.com - March 27 at 11:03 PMOrchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Updateglobenewswire.com - March 27 at 4:17 PMOrchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directorsglobenewswire.com - March 26 at 8:00 AMOrchestra BioMed's AVIM Therapy Demonstrates Promising Results in Controlling Hypertensionmsn.com - March 11 at 8:00 AMOrchestra BioMed to Participate in Upcoming Investor Conferencesglobenewswire.com - March 7 at 8:00 AMOrchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patientsglobenewswire.com - March 6 at 8:37 AMWhy Orchestra BioMed (OBIO) Might Surprise This Earnings Seasonfinance.yahoo.com - February 16 at 2:24 PMOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Short Interest Down 12.8% in Januarymarketbeat.com - January 28 at 8:59 AMOrchestra BioMed Hldgs Stock (NASDAQ:OBIO), Short Interest Reportbenzinga.com - January 19 at 9:01 PMJefferies starts Orchestra BioMed at buy, cites lead program opportunitiesmsn.com - January 19 at 9:01 PMOrchestra BioMed (NASDAQ:OBIO) Coverage Initiated at Jefferies Financial Groupmarketbeat.com - January 19 at 8:15 AMOrchestra BioMed Holdings Inc OBIOmorningstar.com - January 16 at 10:41 AMSilicon Box Accelerates Industry Leadership With Production Commencement at its World Leading Advanced Packaging Facility and Series B Fundraisingsg.finance.yahoo.com - January 8 at 8:54 AMOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO) has caught the attention of hedge funds investors who hold a sizeable 28% stakefinance.yahoo.com - January 3 at 12:03 PMBATL, SNCR and BVN are among pre market gainersmsn.com - December 18 at 11:06 AMmarketbeat.com - December 15 at 3:54 PMOrchestra BioMed Holdings, Inc.: Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Updatefinanznachrichten.de - November 16 at 9:27 AMAnalysts Offer Insights on Healthcare Companies: Orchestra BioMed Holdings (OBIO) and Bicycle Therapeutics (BCYC)markets.businessinsider.com - November 14 at 3:03 PMOrchestra BioMed Holdings, Inc. (OBIO)uk.finance.yahoo.com - November 14 at 10:02 AMOrchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - November 13 at 6:38 PMOrchestra BioMed to Present at Upcoming Investor Conferencesfinance.yahoo.com - November 9 at 9:35 PMAxoGen Non-GAAP EPS of $0.01 beats by $0.07, revenue of $41.3M beats by $1.03Mmsn.com - November 7 at 7:30 AMOBiO Technology (Shanghai) Corp., Ltd.: OBiO Announces Strategic Partnership with Refreshgene to Realize Commercialization of Gene Therapy Productfinanznachrichten.de - October 25 at 8:32 PMOrchestra BioMed Holdings Inc.wsj.com - October 21 at 5:06 PMOrchestra BioMed files prospectus for issuance of up to 1.93M sharesseekingalpha.com - October 12 at 8:53 PMAnalysts Offer Insights on Healthcare Companies: Reneo Pharmaceuticals (RPHM), Pulmonx (LUNG) and Orchestra BioMed Holdings (OBIO)markets.businessinsider.com - October 11 at 7:47 AMLab Notes: Main Line firm spins off company that will focus on OTC product pipelinefinance.yahoo.com - September 22 at 12:27 PMOrchestra BioMed Holdings (OBIO) Gets a Buy from LifeSci Capitalmarkets.businessinsider.com - September 19 at 8:34 PMCrude Oil Rises Over 1%; Revance Therapeutics Shares Plummetmarkets.businessinsider.com - September 19 at 3:34 PMWhy Shares of Orchestra BioMed Jumped Tuesdaymsn.com - September 19 at 3:34 PMRebel's Edge - September 19: $NIO, $BHC, $OBIO, and the Firing of MSU's Football Coachfinance.yahoo.com - September 19 at 3:34 PMOrchestra, Medtronic Join Forcesbaystreet.ca - September 19 at 10:34 AMBoxer Capital LLC Invests $4.89 Million in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO)marketbeat.com - September 12 at 4:02 AMOrchestra BioMed Holdings, Inc.: Orchestra BioMed Reports Second Quarter 2023 Financial Results and Provides Business Updatefinanznachrichten.de - August 11 at 7:18 PMOrchestra BioMed Reports Second Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - August 11 at 3:32 AMChardan Capital Reiterates Orchestra BioMed Holdings (OBIO) Buy Recommendationmsn.com - August 10 at 10:06 AMOrchestra BioMed™ Granted FDA Approval of IDE for U.S. Pivotal Study of Virtue® Sirolimus AngioInfusion Balloon™ in Patients with Coronary In-Stent Restenosisfinance.yahoo.com - August 8 at 12:37 PMOrchestra Biomed Holdings Inc (OBIO)uk.investing.com - August 2 at 8:51 AMOrchestra BioMed Holdings, Inc. (NASDAQ:OBIO) stock most popular amongst retail investors who own 36%, while hedge funds hold 28%finance.yahoo.com - July 31 at 8:18 AMWhy Shares of Orchestra BioMed Holdings Jumped Wednesdayfinance.yahoo.com - June 28 at 2:57 PMOrchestra BioMed Set to Join Russell 3000® and other FTSE Russell Indexesfinance.yahoo.com - June 26 at 12:43 PMmarketbeat.com - March 20 at 1:24 PM Get Orchestra BioMed News Delivered to You Automatically Sign up to receive the latest news and ratings for OBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> OBIO Media Mentions By Week OBIO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OBIO News Sentiment▼0.000.32▲Average Medical News Sentiment OBIO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OBIO Articles This Week▼21▲OBIO Articles Average Week Get Orchestra BioMed News Delivered to You Automatically Sign up to receive the latest news and ratings for OBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: QIPT News Today DRTS News Today CLPT News Today DCTH News Today PROF News Today STIM News Today TELA News Today ARAY News Today KRMD News Today BLUA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OBIO) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orchestra BioMed Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
